title: Interaction between gallopamil and cardiac ryanodine receptors.
abstract: 1. In a sarcoplasmic reticulum fraction obtained from rat hearts, the analysis of equilibrium [3H]-ryanodine binding showed high and low affinity sites (KD = 1.3 nM and 2.8 microM, Bmax = 2.2 pmol mg-1 and 27.8 pmol mg-1). The dissociation rate constant increased at 1 microM vs 4 nM [3H]-ryanodine concentration, and micromolar ryanodine slowed the dissociation of nanomolar ryanodine. 2. The binding of 4 nM [3H]-ryanodine was not affected by gallopamil, while the binding of 100 nM to 18 microM [3H]-ryanodine was partly displaced. Data analysis suggested that gallopamil inhibited low affinity [3H]-ryanodine binding, with IC50 in the micromolar range. 3. Gallopamil decreased the dissociation rate constant of 1 microM [3H]-ryanodine. While gallopamil alone did not affect the dissociation of 4 nM [3H]-ryanodine, gallopamil and micromolar ryanodine slowed it to a greater extent than micromolar ryanodine alone. 4. Our results are consistent with the hypothesis that the ryanodine receptor is a negatively cooperative oligomer, which undergoes a sequential alteration after ryanodine binding. Gallopamil has complex actions: it inhibits ryanodine binding to its low affinity site(s), and probably modulates the cooperativity of ryanodine binding and/or the transition to a receptor state characterized by slow ryanodine dissociation. These molecular actions could account for the previously reported effect of gallopamil on the sarcoplasmic reticulum calcium release channel.
authors.affiliation: Scuola Superiore S. Anna, University of Pisa, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Zucchi
authors.forename: S
authors.initials: S
authors.lastname: Ronca-Testoni
authors.forename: G
authors.initials: G
authors.lastname: Yu
authors.forename: P
authors.initials: P
authors.lastname: Galbani
authors.forename: G
authors.initials: G
authors.lastname: Ronca
authors.forename: M
authors.initials: M
authors.lastname: Mariani
mesh_terms: D000818:Animals; D001244:Association; D001665:Binding Sites; D015220:Calcium Channels / Q000494:pharmacology; D004213:Dissociative Disorders; D004305:Dose-Response Relationship, Drug; D005711:Gallopamil / Q000493:pharmacokinetics / Q000494:pharmacology*; D007700:Kinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D012433:Ryanodine / Q000494:pharmacology*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects*
chemical_list: D015220:Calcium Channels; D012433:Ryanodine; D005711:Gallopamil